In addition, response to anti-TNF treatment with infliximab in RA was associated with reduced expression of an IFN response gene set including OAS1, MX2, and OAS2 (31) supporting a role for AIRE in the disease. This evidence concerns the gene IFNA1 and rheumatoid arthritis.